Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction.
Takahiro AbeTakashi YokotaArata FukushimaNaoya KakutaniTakashi KatayamaRyosuke ShirakawaSatoshi MaekawaHideo NambuYoshikuni ObataKatsuma YamanashiIppei NakanoShingo TakadaIsao YokotaKoichi OkitaShintaro KinugawaToshihisa AnzaiPublished in: Cardiovascular diabetology (2020)
T2DM was associated with lowered peak VO2 in CHF patients with non-reduced or reduced LVEF. The presence of T2DM has a negative impact on CHF patients' exercise capacity, and the degree of impact is partly dependent on their LV systolic function.
Keyphrases
- ejection fraction
- heart failure
- aortic stenosis
- left ventricular
- type diabetes
- end stage renal disease
- high intensity
- blood pressure
- glycemic control
- newly diagnosed
- chronic kidney disease
- cardiac resynchronization therapy
- peritoneal dialysis
- physical activity
- mitral valve
- hypertrophic cardiomyopathy
- metabolic syndrome
- prognostic factors
- adipose tissue
- coronary artery disease
- atrial fibrillation
- insulin resistance
- left atrial
- acute coronary syndrome
- resistance training